Inventor · disambiguated record
Zehong Wan
Also filed as: WAN ZEHONG
35 granted patents·17 pending applications·123 citations·filing 2002–2024
96Inventor score
Files withGLAXO GROUP LTD16GLAXOSMITHKLINE IP DEV LTD13SHUJING BIOPHARMA CO LTD5SMITHKLINE BEECHAM CORP5WAN ZEHONG4
Top patents by PatentIndex Score
52 records- 0189US7276521B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2004·Granted Oct 2, 2007·34 cites·32 claims
- 0289US7166639B2NF-κB inhibitorsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Jan 23, 2007·38 cites·17 claims
- 0384US7563803B2M3 muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2007·Granted Jul 21, 2009·5 cites·23 claims
- 0484US2024300965A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0583US7479558B2Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivativesGLAXO GROUP LTD·Filed 2006·Granted Jan 20, 2009·5 cites·69 claims
- 0683US7439255B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2004·Granted Oct 21, 2008·14 cites·31 claims
- 0782US9783546B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 10, 2017·2 cites·16 claims
- 0880US7576096B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2007·Granted Aug 18, 2009·3 cites·5 claims
- 0977US9815841B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Nov 14, 2017·2 cites·13 claims
- 1077US7579361B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2007·Granted Aug 25, 2009·2 cites·19 claims
- 1175US7678801B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Mar 16, 2010·2 cites·76 claims
- 1272US10618901B2LRRK2 inhibitors for the treatment of Parkinson's diseaseGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Apr 14, 2020·1 cites·21 claims
- 1372US9174968B2Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by LP-PLA2GLAXO GROUP LTD·Filed 2014·Granted Nov 3, 2015·1 cites·14 claims
- 1472US7674789B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Mar 9, 2010·1 cites·71 claims
- 1570US10125141B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Nov 13, 2018·1 cites·30 claims
- 1670US8637536B2Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2JIN YUN·Filed 2011·Granted Jan 28, 2014·1 cites·2 claims
- 1770US8084449B2Dual pharmacophores—PDE4-muscarinic antagonisticsCALLAHAN JAMES FRANCIS·Filed 2009·Granted Dec 27, 2011·2 cites·13 claims
- 1868US11999746B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Jun 4, 2024·0 cites·14 claims
- 1968US8975400B22,3-dihydroimidazo[1, 2-c] pyrimidin-5(1 H)-one compounds use as LP-PLA2 inhibitorsWAN ZEHONG·Filed 2012·Granted Mar 10, 2015·2 cites·14 claims
- 2067US10975081B2Substituted fused pyrazole compounds and their use as LRRK2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 13, 2021·1 cites·18 claims
- 2167US10087186B2Compounds as LRRK2 kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 2, 2018·1 cites·15 claims
- 2267US7906531B2M3 muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2009·Granted Mar 15, 2011·0 cites·19 claims
- 2366US8067408B2Dual pharmacophores—PDE4-muscarinic antagonisticsCALLAHAN JAMES FRANCIS·Filed 2009·Granted Nov 29, 2011·1 cites·3 claims
- 2465US9273054B2Substituted pyrimido[1,6-a]pyrimidines as Lp-PLA2 inhibitorsWAN ZEHONG·Filed 2012·Granted Mar 1, 2016·1 cites·12 claims
- 2565US8859573B2Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2WAN ZEHONG·Filed 2011·Granted Oct 14, 2014·1 cites·13 claims
- 2665US8207176B2CompoundsCALLAHAN JAMES F·Filed 2006·Granted Jun 26, 2012·1 cites·31 claims
- 2764US8354416B27,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinaseGLAXO GROUP LTD·Filed 2008·Granted Jan 15, 2013·0 cites·30 claims
- 2863US2024336583A1Benzo-ring-containing derivative, and preparation method therefor and use thereofSHUJING BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2961US10428078B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Oct 1, 2019·0 cites·28 claims
- 3061US7507747B2Muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2004·Granted Mar 24, 2009·1 cites·28 claims
- 3160US2024368115A1Regulator containing tricyclic derivative, preparation method therefor and application thereofSHUJING BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 3259US2010093765A1Novel compoundsCALLAHAN JAMES F·Filed 2009·Application pending·0 cites
- 3359US2010093766A1Novel compoundsCALLAHAN JAMES F·Filed 2009·Application pending·0 cites
- 3458US2009048444A1Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one DerivativesGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 3558US2024190888A1Spiro-containing derivative, and preparation method therefor and use thereofSHUJING BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 3656US2023339949A1HETEROCYCLIC SUBSTITUTED FUSED y-CARBOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE THEREOF AND USE THEREOFSHUJING BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 3756US2014113922A1CompoundsGLAXO GROUP LTD·Filed 2013·Application pending·0 cites
- 3852US9051325B2Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2GLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jun 9, 2015·0 cites·6 claims
- 3950US2014378487A1Tricyclic compounds, preparation methods, and their usesGLAXO GROUP LTD·Filed 2014·Application pending·0 cites
- 4049US2024398772A1Oxaspiro derivative, and preparation method therefor and use thereofSHUJING BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 4147US9296755B23,4-dihydro-1H-pyrimido[1,6-a]pyrimidin-6(2H)-one compounds and their therapeutic applicationsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Mar 29, 2016·0 cites·12 claims
- 4246US8871928B2Tricyclic compounds, preparation methods, and their usesWAN ZEHONG·Filed 2011·Granted Oct 28, 2014·0 cites·15 claims
- 4346US8071588B2Dual pharmacophores—PDE4-muscarinic antagonisticsCALLAHAN JAMES FRANCIS·Filed 2009·Granted Dec 6, 2011·0 cites·3 claims
- 4446US2008051416A1Novel CompoundsSMITHKLINE BEECHAM CORP·Filed 2005·Application pending·0 cites
- 4545US9708330B22,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jul 18, 2017·0 cites·8 claims
- 4645US7629350B2CompoundsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Dec 8, 2009·0 cites·7 claims
- 4745US7300952B2NF-κb inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Nov 27, 2007·0 cites·2 claims
- 4845US2015344485A1Bicyclic pyrimidone compounds as inhibitors of lp-pla2GLAXOSMITHKLINE IP DEV LTD·Filed 2014·Application pending·0 cites
- 4945US2006094726A1Quinoline derivatives as nk-2 and nk-3 receptor antagonistsKERNS JEFFREY·Filed 2004·Application pending·0 cites
- 5045US2007185148A1M3 muscarinic acetylchoine receptor antagonistsGLAXO GROUP LTD·Filed 2004·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →